Watch Live

Tweet TWEET

PCI Biotech Holding : PCI Biotech: Resignation of Board member

        PCI Biotech Holding : PCI Biotech: Resignation of Board member

Oslo, 22 January 2013 - PCI Biotech (PCIB) announces that Dr Flemming Ørnskov,
member of the Board of Directors, will resign with immediate effect. Dr
Ørnskov has recently been appointed Chief Executive Designate, and member of
the board of directors, of Shire plc, a global pharmaceutical company, and is
therefore no longer able to continue as Board member of PCI Biotech. Dr
Ørnskov has been a member of the Board of Directors of PCI Biotech since 2008.

- Flemming Ørnskov possesses a unique combination of medical and business
skills, and we are very thankful for his contributions to the development of
PCI Biotech. We wish him all the best in his new role as CEO designate of
Shire, said Erling Øverland, Chairman of the Board of PCI Biotech.

-It has been interesting and positively challenging to be part of the Board of
Directors of PCI Biotech. I am truly sorry to resign from the Board of
Directors but it is no longer commensurate with my current and future
obligations at Shire. PCI Biotech has an innovative and interesting technology
with promising early results, and I wish the company all the best with the
further development of the technology and company as such, said Dr Flemming
Ørnskov.

The process to find a new Board member will start immediately, and the
election committee intends to propose a new Board member for the ordinary
general meeting on May 6th, 2013.

For more information about PCI Biotech, visit: www.pcibiotech.com

Contact information:
PCI Biotech Holding ASA, Strandveien 55, N-1366 Lysaker
Erling Øverland, Chairman, Mobile: +47 915 56 542
Per Walday, CEO, pw@pcibiotech.no, Mobile: +47 917 93 429


This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: PCI Biotech Holding via Thomson Reuters ONE
HUG#1672188